Search
Login
My Portfolios Login
TradeMachine® Login
CML Research Pro Login
Get TradeMachine®
Get CML Research
Compare Products
Home
My Portfolios
CMLViz News
Breaking
Stock
Scanner
Tear Sheet
News
Profile
Stats
Stock Chart
Pivot Points
Financial Charts
Holders
Analysts
Day Trader
Back-Tester
SPX
3,825.33
+40.17
(
+1.05%
)
Dow 30
+1.00%
QQQ
+0.66%
VIX
27.53
-1.18
(
-4.11%
)
Indaptus Therapeutics Inc
NASDAQ:INDP 3:59:51 PM EDT
3.13
+0.52
(
+19.92%
)
Products
Indaptus Therapeutics Announces FDA Clearance Of INDA To Initiate Phase 1 Clinical Trial Of DECOY20 In Solid Tumors
Published: 05/19/2022 11:07 GMT
INDP
Indaptus Therapeutics Inc (
INDP
)
- Indaptus Therapeutics Announces FDA Clearance of Investigational New Drug Application to Initiate Phase 1 Clinical Trial of Decoy20 in Solid Tumors.